002793 罗欣药业
已收盘 01-13 15:00:00
资讯
新帖
简况
股市必读:罗欣药业(002793)股东户数3.83万户,较上期减少0.94%
中金财经 · 08:00
股市必读:罗欣药业(002793)股东户数3.83万户,较上期减少0.94%
罗欣药业:公司最新一期股东总户数为38,283
证券之星 · 01-12 15:42
罗欣药业:公司最新一期股东总户数为38,283
罗欣药业(002793)披露为控股子公司提供担保的进展公告,1月8日股价上涨1.85%
证券之星 · 01-08
罗欣药业(002793)披露为控股子公司提供担保的进展公告,1月8日股价上涨1.85%
罗欣药业(002793)披露转让控股子公司股权进展,1月7日股价下跌1.82%
证券之星 · 01-07
罗欣药业(002793)披露转让控股子公司股权进展,1月7日股价下跌1.82%
罗欣药业:截至2025年12月31日股东户数为38,648
证券之星 · 01-05
罗欣药业:截至2025年12月31日股东户数为38,648
每周股票复盘:罗欣药业(002793)泰欣赞进院近2500家销售增140%
证券之星 · 01-03
每周股票复盘:罗欣药业(002793)泰欣赞进院近2500家销售增140%
罗欣药业(002793)披露转让控股子公司股权暨被动形成财务资助公告,12月30日股价下跌0.42%
证券之星 · 2025-12-30
罗欣药业(002793)披露转让控股子公司股权暨被动形成财务资助公告,12月30日股价下跌0.42%
罗欣药业:交银施罗德基金、广发基金等多家机构于12月28日调研我司
证券之星 · 2025-12-30
罗欣药业:交银施罗德基金、广发基金等多家机构于12月28日调研我司
罗欣药业(002793)披露为控股子公司提供担保的进展公告,12月26日股价下跌0.81%
证券之星 · 2025-12-26
罗欣药业(002793)披露为控股子公司提供担保的进展公告,12月26日股价下跌0.81%
罗欣药业:公司最新一期股东总户数为39,271
证券之星 · 2025-12-23
罗欣药业:公司最新一期股东总户数为39,271
12月17日罗欣药业现1859.19万元大宗交易
证券之星 · 2025-12-17
12月17日罗欣药业现1859.19万元大宗交易
罗欣药业:截止至2025年12月10日股东总户数为39,227
证券之星 · 2025-12-11
罗欣药业:截止至2025年12月10日股东总户数为39,227
罗欣药业(002793)披露2024年员工持股计划首次授予部分第一个锁定期届满暨解锁条件成就公告,12月01日股价下跌0.55%
证券之星 · 2025-12-01
罗欣药业(002793)披露2024年员工持股计划首次授予部分第一个锁定期届满暨解锁条件成就公告,12月01日股价下跌0.55%
罗欣药业(002793)披露为控股子公司提供担保的进展公告,11月28日股价上涨1.12%
证券之星 · 2025-11-28
罗欣药业(002793)披露为控股子公司提供担保的进展公告,11月28日股价上涨1.12%
罗欣药业:截止至2025年11月20日股东总户数为39,739
证券之星 · 2025-11-25
罗欣药业:截止至2025年11月20日股东总户数为39,739
罗欣药业(002793)披露选举非独立董事及修订多项议案,11月14日股价上涨3.78%
证券之星 · 2025-11-14
罗欣药业(002793)披露选举非独立董事及修订多项议案,11月14日股价上涨3.78%
股市必读:罗欣药业(002793)11月7日董秘有最新回复
证券之星 · 2025-11-10
股市必读:罗欣药业(002793)11月7日董秘有最新回复
罗欣药业:替戈拉生片根除幽门螺杆菌
证券之星 · 2025-11-07
罗欣药业:替戈拉生片根除幽门螺杆菌
罗欣药业:截止至2025年10月31日,公司股东总户数为43,927
证券之星 · 2025-11-07
罗欣药业:截止至2025年10月31日,公司股东总户数为43,927
罗欣药业(002793)股东山东罗欣控股有限公司质押1.01亿股,占总股本9.32%
证券之星 · 2025-11-03
罗欣药业(002793)股东山东罗欣控股有限公司质押1.01亿股,占总股本9.32%
加载更多
公司概况
公司名称:
罗欣药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2016-04-15
主营业务:
罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是医药产品。
发行价格:
11.97
{"stockData":{"symbol":"002793","market":"SZ","secType":"STK","nameCN":"罗欣药业","latestPrice":5.04,"timestamp":1768287783000,"preClose":4.99,"halted":0,"volume":24306326,"delay":0,"changeRate":0.01,"floatShares":1086000000,"shares":1088000000,"eps":-0.6227,"marketStatus":"已收盘","change":0.05,"latestTime":"01-13 15:00:00","open":5.01,"high":5.14,"low":4.99,"amount":123000000,"amplitude":0.0301,"askPrice":5.05,"askSize":443,"bidPrice":5.04,"bidSize":352,"shortable":0,"etf":0,"ttmEps":-0.6227,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":4.99,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":5.49,"lowLimit":4.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1087588486,"isCdr":false,"pbRate":3.74,"roa":"--","roe":"1.62%","epsLYR":-0.91,"committee":0.003019,"marketValue":5481000000,"turnoverRate":0.0224,"status":0,"floatMarketCap":5473000000},"requestUrl":"/m/hq/s/002793","defaultTab":"news","newsList":[{"id":"2603522779","title":"股市必读:罗欣药业(002793)股东户数3.83万户,较上期减少0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603522779","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603522779?lang=zh_cn&edition=full","pubTime":"2026-01-13 08:00","pubTimestamp":1768262439,"startTime":"0","endTime":"0","summary":"来自股本股东变化:截至2026年1月9日,罗欣药业股东户数为3.83万户,较前期减少365户,户均持股升至2.84万股。资金流向1月12日主力资金净流出1174.94万元;游资资金净流入310.47万元;散户资金净流入864.47万元。股东户数变动近日罗欣药业披露,截至2026年1月9日公司股东户数为3.83万户,较12月31日减少365.0户,减幅为0.94%。户均持股数量由上期的2.81万股增加至2.84万股,户均持股市值为14.29万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260113/31936006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0132","BK0201","002793","08058","BK0239","BK0001"],"gpt_icon":0},{"id":"2602591038","title":"罗欣药业:公司最新一期股东总户数为38,283","url":"https://stock-news.laohu8.com/highlight/detail?id=2602591038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602591038?lang=zh_cn&edition=full","pubTime":"2026-01-12 15:42","pubTimestamp":1768203728,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)01月12日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至1月10日的股东人数是多少?罗欣药业回复:尊敬的投资者,您好!公司最新一期(2026年1月9日)股东总户数为38,283。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200015194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002793","BK0132","08058","BK0001","BK0239"],"gpt_icon":0},{"id":"2601398561","title":"罗欣药业(002793)披露为控股子公司提供担保的进展公告,1月8日股价上涨1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601398561","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601398561?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:30","pubTimestamp":1767882638,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘,罗欣药业报收于4.95元,较前一交易日上涨1.85%,最新总市值为53.84亿元。公司近日发布公告称,罗欣药业集团股份有限公司近日与中国农业银行股份有限公司临沂罗庄支行签署《最高额保证合同》,为控股子公司山东罗欣药业集团股份有限公司提供最高额5,000万元的连带责任保证担保,用于其开展无追索权保理业务。公司及控股子公司对外担保总余额为115,232.57万元,占最近一期经审计净资产的83.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800039132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0239","BK0132","BK0201","002793","BK0001"],"gpt_icon":0},{"id":"2601180182","title":"罗欣药业(002793)披露转让控股子公司股权进展,1月7日股价下跌1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601180182","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601180182?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:25","pubTimestamp":1767795922,"startTime":"0","endTime":"0","summary":"公司近日发布公告称,罗欣药业集团股份有限公司于2025年12月29日召开董事会,同意下属子公司山东罗欣将其持有的乐康制药100%股权转让给临沂君康,转让对价为6,250万元。股权转让后,乐康制药不再纳入公司合并报表范围。截至公告日,乐康制药尚欠山东罗欣280.05万元本金及利息,该款项将被动形成对外财务资助,约定于2026年10月26日前清偿完毕。乐康制药已完成工商变更登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002793","BK0001","08058","BK0132","BK0239"],"gpt_icon":0},{"id":"2601003087","title":"罗欣药业:截至2025年12月31日股东户数为38,648","url":"https://stock-news.laohu8.com/highlight/detail?id=2601003087","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601003087?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:15","pubTimestamp":1767597322,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)01月04日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至12月31日的股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至2025年12月31日,公司股东总户数为38,648。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0132","002793","BK0239","BK0001","BK0201"],"gpt_icon":0},{"id":"2600098389","title":"每周股票复盘:罗欣药业(002793)泰欣赞进院近2500家销售增140%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098389","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600098389?lang=zh_cn&edition=full","pubTime":"2026-01-03 04:13","pubTimestamp":1767384789,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,罗欣药业报收于4.8元,较上周的4.87元下跌1.44%。本周,罗欣药业12月29日盘中最高价报4.86元。本周关注点来自机构调研要点:泰欣赞2025年上半年进院数量近2500家,销量同比增140%。来自公司公告汇总:拟转让乐康制药100%股权,交易对价6,250万元。销售费用率下降主要受益于泰欣赞销售收入规模化增长带来的规模效应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","08058","BK0201","BK0001","002793"],"gpt_icon":0},{"id":"2595959937","title":"罗欣药业(002793)披露转让控股子公司股权暨被动形成财务资助公告,12月30日股价下跌0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595959937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595959937?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:58","pubTimestamp":1767088686,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘,罗欣药业报收于4.78元,较前一交易日下跌0.42%,最新总市值为51.99亿元。近日,罗欣药业集团股份有限公司发布关于转让控股子公司股权暨被动形成财务资助的公告。公告显示,公司下属子公司山东罗欣拟将其持有的山东罗欣乐康制药有限公司100%股权转让给临沂君康生物有限公司,转让对价为6,250万元。因转让前山东罗欣向乐康制药提供借款280.05万元本金及利息,交易完成后将被动形成对外财务资助,约定于2026年10月26日前清偿完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000030892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0001","08058","BK0132","BK0239"],"gpt_icon":0},{"id":"2595175752","title":"罗欣药业:交银施罗德基金、广发基金等多家机构于12月28日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2595175752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595175752?lang=zh_cn&edition=full","pubTime":"2025-12-30 10:01","pubTimestamp":1767060086,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年12月29日罗欣药业发布公告称交银施罗德基金、广发基金、国海证券、中邮证券于2025年12月28日调研我司。公司分别于2025年 9月 29日、2025年 11月 14日召开董事会、股东会审议,于2025年9月30日在巨潮资讯网披露了本次发行预案,发行决议的有效期为自公司股东会审议通过之日起12个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000010878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0001","BK0132","BK0239","BK0201","002793"],"gpt_icon":0},{"id":"2594294288","title":"罗欣药业(002793)披露为控股子公司提供担保的进展公告,12月26日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294288","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594294288?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:43","pubTimestamp":1766760193,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,罗欣药业报收于4.87元,较前一交易日下跌0.81%,最新总市值为52.97亿元。公司近日发布公告称,罗欣药业集团股份有限公司为控股子公司山东罗欣药业集团股份有限公司在中国建设银行股份有限公司临沂罗庄支行的银行授信提供最高额保证担保,本金最高额不超过人民币1,000万元。截至公告日,公司对山东罗欣的担保余额为100,711.94万元,山东罗欣可用担保额度剩余48,148.40万元。公司及控股子公司对外担保总余额占最近一期经审计净资产的77.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0132","08058","BK0001","BK0239"],"gpt_icon":0},{"id":"2593454587","title":"罗欣药业:公司最新一期股东总户数为39,271","url":"https://stock-news.laohu8.com/highlight/detail?id=2593454587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593454587?lang=zh_cn&edition=full","pubTime":"2025-12-23 08:51","pubTimestamp":1766451068,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至12月20日的股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!公司最新一期(2025年12月19日)股东总户数为39,271。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300006194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002793","08058","BK0132","BK0001","BK0239"],"gpt_icon":0},{"id":"2592955079","title":"12月17日罗欣药业现1859.19万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2592955079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592955079?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:42","pubTimestamp":1765964527,"startTime":"0","endTime":"0","summary":"证券之星消息,12月17日罗欣药业发生大宗交易,交易数据如下:大宗交易成交价格4.82元,相对当日收盘价折价1.83%,成交385.73万股,成交金额1859.19万元,买方营业部为中信证券股份有限公司北京总部证券营业部,卖方营业部为东方财富证券股份有限公司上海分公司。近三个月该股共发生1笔大宗交易,合计成交3.86万手,折价成交1笔。截至2025年12月17日收盘,罗欣药业报收于4.91元,上涨0.41%,换手率1.03%,成交量11.16万手,成交额5416.6万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700027736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","BK0132","002793","08058","BK0201"],"gpt_icon":0},{"id":"2590677165","title":"罗欣药业:截止至2025年12月10日股东总户数为39,227","url":"https://stock-news.laohu8.com/highlight/detail?id=2590677165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590677165?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:06","pubTimestamp":1765436785,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2025年12月10日公司股东人数多少?罗欣药业回复:尊敬的投资者,您好!截止至2025年12月10日,公司股东总户数为39,227。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100019003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0001","BK0132","BK0239","BK0201","002793"],"gpt_icon":0},{"id":"2588477558","title":"罗欣药业(002793)披露2024年员工持股计划首次授予部分第一个锁定期届满暨解锁条件成就公告,12月01日股价下跌0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588477558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588477558?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:23","pubTimestamp":1764599011,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘,罗欣药业报收于5.38元,较前一交易日下跌0.55%,最新总市值为58.51亿元。该股当日开盘5.41元,最高5.44元,最低5.36元,成交额达6870.54万元,换手率为1.17%。公告显示,公司2024年员工持股计划首次授予部分第一个锁定期将于2025年12月3日届满,解锁条件已成就。2024年公司营业收入同比增长11.99%,达到业绩考核目标。首次授予实际认购人数为161人,其中152人为当前持有人。符合解锁条件的股份数量为8,512,251股,占公司总股本的0.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100036804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002793","BK0201","08058","BK0001"],"gpt_icon":0},{"id":"2586430738","title":"罗欣药业(002793)披露为控股子公司提供担保的进展公告,11月28日股价上涨1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586430738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586430738?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:16","pubTimestamp":1764339370,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘,罗欣药业报收于5.41元,较前一交易日上涨1.12%,最新总市值为58.84亿元。公司近日发布公告称,罗欣药业集团股份有限公司为控股子公司山东罗欣药业集团股份有限公司提供最高额人民币壹亿元的连带责任保证担保,用于其银行授信。本次担保后,公司对山东罗欣的担保余额为109,787.51万元,山东罗欣可用担保额度剩余49,148.40万元。山东罗欣生产经营正常,资信状况良好,公司对其具有实际控制权,担保风险可控。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800039846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","08058","BK0239","BK0132","BK0201","BK0001"],"gpt_icon":0},{"id":"2586426384","title":"罗欣药业:截止至2025年11月20日股东总户数为39,739","url":"https://stock-news.laohu8.com/highlight/detail?id=2586426384","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586426384?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:06","pubTimestamp":1764054384,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)11月25日在投资者关系平台上答复投资者关心的问题。投资者提问:请问11月20日的股东人数多少,谢谢罗欣药业回复:尊敬的投资者,您好!截止至2025年11月20日,公司股东总户数为39,739。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500016941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0001","BK0239","08058","BK0201"],"gpt_icon":0},{"id":"2583504252","title":"罗欣药业(002793)披露选举非独立董事及修订多项议案,11月14日股价上涨3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583504252","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583504252?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:20","pubTimestamp":1763130037,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,罗欣药业报收于5.77元,较前一交易日上涨3.78%,最新总市值为62.75亿元。近日,罗欣药业发布公告称,公司于2025年11月14日召开2025年第六次临时股东会,审议通过了多项议案。其中包括修订公司章程、董事会议事规则,选举韩风生为第五届董事会非独立董事,以及关于公司2025年度向特定对象发行A股股票的相关议案。所有议案均获通过,会议召集召开程序合法,表决结果有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400041586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0001","BK0132","BK0239","BK0201","002793"],"gpt_icon":0},{"id":"2582907478","title":"股市必读:罗欣药业(002793)11月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582907478","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582907478?lang=zh_cn&edition=full","pubTime":"2025-11-10 01:24","pubTimestamp":1762709052,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,罗欣药业报收于5.4元,上涨0.0%,换手率1.51%,成交量16.37万手,成交额8825.11万元。董秘最新回复投资者: 公司是否有生产幽门螺杆菌专用药品例如克拉霉素、甲硝唑、左氧氟沙星和阿莫西林董秘: 尊敬的投资者,您好。公司未生产利福特尼唑药,公司1类新药替戈拉生片与适当的抗生素联用以根除幽门螺杆菌。截止至2025年10月31日,公司股东总户数为43,927。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000000534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002793","BK0132","BK0001","08058"],"gpt_icon":0},{"id":"2581307039","title":"罗欣药业:替戈拉生片根除幽门螺杆菌","url":"https://stock-news.laohu8.com/highlight/detail?id=2581307039","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581307039?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:54","pubTimestamp":1762505655,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)11月07日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司是否生产幽门螺杆菌的利福特尼唑药罗欣药业回复:尊敬的投资者,您好。公司未生产利福特尼唑药,公司1类新药替戈拉生片与适当的抗生素联用以根除幽门螺杆菌。此前,公司开展的根除幽门螺杆菌感染的Ⅲ期临床试验证实了在中国幽门螺杆菌感染患者中,含替戈拉生的铋剂四联疗法幽门螺杆菌根除率(93.5%)优效于含艾司奥美拉唑的铋剂四联疗法(86.4%)。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700026082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","08058","BK0132","BK0201","002793","BK0239"],"gpt_icon":0},{"id":"2581077856","title":"罗欣药业:截止至2025年10月31日,公司股东总户数为43,927","url":"https://stock-news.laohu8.com/highlight/detail?id=2581077856","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581077856?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:36","pubTimestamp":1762504577,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)11月07日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止10月31日股东户数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至2025年10月31日,公司股东总户数为43,927。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700025706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","08058","BK0239","BK0201","002793","BK0132"],"gpt_icon":0},{"id":"2580299668","title":"罗欣药业(002793)股东山东罗欣控股有限公司质押1.01亿股,占总股本9.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580299668","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580299668?lang=zh_cn&edition=full","pubTime":"2025-11-03 18:33","pubTimestamp":1762166022,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业11月3日公开信息显示,股东山东罗欣控股有限公司向山东省国际信托股份有限公司合计质押1.01亿股,占总股本9.32%。质押详情见下表:截止本公告日,股东山东罗欣控股有限公司已累计质押股份1.37亿股,占其持股总数的57.95%。罗欣药业主营业务:医药产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300028120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0201","BK0001","002793","BK0239","BK0132"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768297050184,"stockEarnings":[{"period":"1week","weight":0.0142},{"period":"1month","weight":0.0081},{"period":"3month","weight":0.0225},{"period":"6month","weight":-0.0099},{"period":"1year","weight":0.3342},{"period":"ytd","weight":0.0396}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"罗欣药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38283人(较上一季度减少0.94%)","perCapita":"28365股","listingDate":"2016-04-15","address":"山东省临沂市罗庄区罗七路18号4号楼","registeredCapital":"108758万元","survey":" 罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是医药产品。","listedPrice":11.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,002793,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}